ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 930,51
-0,68%
Dow Jones
37 995,06
0,24%
DAX
17 928,38
0,04%
Brent Oil
83,435
-0,13%
Bitcoin
59 137,05
1,54%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zura Bio Ltd (ZURA)

  7. Zura Bio Ltd (ZURA) Actualités

ZURA Zura Bio Ltd

4,275
0,125 (3,01%)
Dernière mise à jour : 16:30:48
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Zura Bio Ltd ZURA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,125 3,01% 4,275 16:30:48
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,22 4,12 4,30 4,15
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/4/202415:22BWZura Bio Announces Oversubscribed $112.5 Million Private..
08/4/202412:00BWZura Bio Announces Robert Lisicki as CEO and Director
28/3/202411:00BWZura Bio Reports Full Year 2023 Financial Results, Business..
04/3/202412:00BWZura Bio Announces Participation at March Conferences
23/2/202422:30EDGAR2Form 8-K - Current report
14/2/202415:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202412:00BWZura Bio Announces Participation at February Investor..
26/1/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:25EDGAR2Form 8-K - Current report
08/1/202412:03EDGAR2Form 8-K - Current report
08/1/202412:00BWZura Bio Continues to Strengthen Leadership with Appointment..
03/1/202412:04EDGAR2Form 8-K - Current report
03/1/202412:00BWZura Bio to Present at the 42nd Annual J.P. Morgan..
04/12/202312:00BWZura Bio Announces Two Immunology Abstracts Presented at the..
17/11/202323:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202312:00BWZura Bio Appoints Arnout Ploos van Amstel to its Board of..
13/11/202312:30BWZura Bio Reports Third Quarter 2023 Financial Results and..
25/10/202322:30EDGAR2Form 8-K - Current report
03/10/202303:30EDGAR2Form 8-K - Current report
14/9/202323:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/9/202322:23EDGAR2Form 8-K - Current report
12/9/202311:00BWZura Bio Enters into Sponsored Research Agreement with..
25/8/202303:54EDGAR2Form S-1/A - General form for registration of securities..
14/8/202313:00BWZura Bio Reports Second Quarter 2023 Financial Results and..
11/8/202323:13EDGAR2Form S-1/A - General form for registration of securities..
27/7/202323:07EDGAR2Form 8-K - Current report
21/7/202323:28EDGAR2Form S-1/A - General form for registration of securities..
23/6/202312:30BWZura Bio to Join the Russell 2000® and Russell 3000® Indexes
06/6/202310:00BWZura Bio Completes Approximately $80 Million Financing with..

Dernières Valeurs Consultées

NASDAQ
ZURA
Zura Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés